This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Daniel Macarthur
Introduction
Daniel Macarthur is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of genetics, particularly in diagnosing and treating COL6-related disorders. His work has the potential to impact many lives by identifying individuals at risk for these disorders.
Latest Patents
Macarthur holds a patent for "Diagnosing COL6-related disorders and methods for treating same." This patent focuses on a single nucleotide polymorphism (SNP) that leads to the development of a Type VI collagen, alpha 1 chain-related disorder. The patent outlines the use of this SNP to identify individuals at risk for developing COL6-related disorders (COL6-RD). Additionally, it provides antisense oligomers for treating individuals at risk for COL6-RD, along with methods for screening compounds that may serve as therapeutic agents.
Career Highlights
Macarthur works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role in this organization allows him to contribute to important health initiatives and research efforts aimed at improving patient outcomes.
Collaborations
Macarthur has collaborated with notable colleagues such as Veronique Bolduc and Steve Wilton. These partnerships enhance the research and development of innovative solutions in the field of genetics.
Conclusion
Daniel Macarthur's work exemplifies the impact of innovation in the medical field, particularly in the diagnosis and treatment of genetic disorders. His contributions are paving the way for advancements that could significantly improve the lives of those affected by COL6-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
